Cognitive peptides benefit all adult age groups: younger users (20s-30s) often seek performance enhancement, middle-aged users (40s-50s) address early cognitive decline, and older users (60+) use them for neuroprotection and memory support.
Age-stratified research shows efficacy across the lifespan with different primary benefits depending on baseline cognitive status.